{"DataElement":{"publicId":"7533688","version":"1","preferredName":"Cancer Outcome EORTC Quality of Life Questionnaire-Core 30 Assessment Text","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._The result of an action._An integrated system for assessing the quality of life of cancer patients participating in clinical trials and other types of research. It incorporates five functional scales: Physical, Role, Cognitive, Emotional, and Social Functioning; three symptom scales: Fatigue, Pain, and Nausea/Vomiting; a Global Health Status/QoL scale; and six single item scales: Dyspnea, Insomnia, Appetite Loss, Constipation, Diarrhea, and Financial Difficulties._a free text field to specify information on the evaluations of the patient and the patient's disease","longName":"Mali_Outc_EORT_ASSESS_TXT","context":"PhenX","contextVersion":"1","DataElementConcept":{"publicId":"7533686","version":"1","preferredName":"Malignant Neoplasm Outcome EORTC Quality of Life Questionnaire-Core 30","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._The result of an action._An integrated system for assessing the quality of life of cancer patients participating in clinical trials and other types of research. It incorporates five functional scales: Physical, Role, Cognitive, Emotional, and Social Functioning; three symptom scales: Fatigue, Pain, and Nausea/Vomiting; a Global Health Status/QoL scale; and six single item scales: Dyspnea, Insomnia, Appetite Loss, Constipation, Diarrhea, and Financial Difficulties.","longName":"Mali_Outc_EORT","context":"PhenX","contextVersion":"1","ObjectClass":{"publicId":"7533641","version":"1","preferredName":"Malignant Neoplasm Outcome","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.:The result of an action.","longName":"C9305:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6972473-2687-3DD5-E053-4EBD850A3CFD","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"PANH","dateCreated":"2020-12-17","modifiedBy":"ONEDATA","dateModified":"2020-12-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7544289","version":"1","preferredName":"EORTC Quality of Life Questionnaire-Core 30","preferredDefinition":"An integrated system for assessing the quality of life of cancer patients participating in clinical trials and other types of research. It incorporates five functional scales: Physical, Role, Cognitive, Emotional, and Social Functioning; three symptom scales: Fatigue, Pain, and Nausea/Vomiting; a Global Health Status/QoL scale; and six single item scales: Dyspnea, Insomnia, Appetite Loss, Constipation, Diarrhea, and Financial Difficulties.","longName":"C176836","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EORTC Quality of Life Questionnaire-Core 30","conceptCode":"C176836","definition":"An integrated system for assessing the quality of life of cancer patients participating in clinical trials and other types of research. It incorporates five functional scales: Physical, Role, Cognitive, Emotional, and Social Functioning; three symptom scales: Fatigue, Pain, and Nausea/Vomiting; a Global Health Status/QoL scale; and six single item scales: Dyspnea, Insomnia, Appetite Loss, Constipation, Diarrhea, and Financial Difficulties.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B806B214-CB86-22CF-E053-4EBD850AE733","latestVersionIndicator":"Yes","beginDate":"2021-01-03","endDate":null,"createdBy":"PANH","dateCreated":"2021-01-03","modifiedBy":"ONEDATA","dateModified":"2021-01-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B6ADD55E-04A6-33BD-E053-4EBD850AE930","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"PANH","dateCreated":"2020-12-17","modifiedBy":"PANH","dateModified":"2021-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018321","version":"1","preferredName":"Assessment Text","preferredDefinition":"a free text field to specify information on the evaluations of the patient and the patient's disease","longName":"ASSESS_TXT","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184342","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"Text","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2103-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2BC789C-301C-4477-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-26","endDate":null,"createdBy":"PWEST","dateCreated":"2002-12-26","modifiedBy":"CAMPBELB","dateModified":"2008-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2793652","version":"1","longName":"PhenX","context":"PhenX","ClassificationSchemeItems":[{"publicId":"6641384","version":"1","longName":"Cancer Outcomes & Survivorship","context":"PhenX"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Data Element Cancer Outcome EORTC Quality of Life Questionnaire-Core 30 Assessment Text does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Cancer Outcome EORTC Quality of Life Questionnaire-Core 30 Assessment Text does not have Preferred Question Text","url":null,"context":"PhenX"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B69606DB-9C98-4A19-E053-4EBD850A9101","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"PANH","dateCreated":"2020-12-17","modifiedBy":"PANH","dateModified":"2021-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}